Pharmaron Beijing Sets 28 April 2026 Board Meeting to Approve Q1 2026 Results

Bulletin Express04-14

Pharmaron Beijing Co., Ltd. announced that its board of directors will convene on 28 April 2026 to review and approve the consolidated financial results for the three months ended 31 March 2026. The company plans to publish the first-quarter figures following the meeting.

The board currently comprises nine members: Executive Directors Dr. Lou Boliang (Chairman), Mr. Lou Xiaoqiang and Ms. Zheng Bei; Employee Representative Director Mr. Li Shing Chung Gilbert; Non-executive Directors Mr. Li Jiaqing and Ms. Wan Xuan; and Independent Non-executive Directors Ms. Li Lihua, Prof. Tsang King Fung and Mr. Yu Jian. The notice was issued in Beijing on 14 April 2026 and signed by Chairman Dr. Lou Boliang.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1172374529?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-14 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172374529","market":"us","top_or_hot":-1,"title":"Pharmaron Beijing Sets 28 April 2026 Board Meeting to Approve Q1 2026 Results","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. announced that its board of directors will convene on 28 April 2026 to review and approve the consolidated financial results for the three months ended 31 March 2026. The company plans to publish the first-quarter figures following the meeting.</p>\n<p>The board currently comprises nine members: Executive Directors Dr. Lou Boliang (Chairman), Mr. Lou Xiaoqiang and Ms. Zheng Bei; Employee Representative Director Mr. Li Shing Chung Gilbert; Non-executive Directors Mr. Li Jiaqing and Ms. Wan Xuan; and Independent Non-executive Directors Ms. Li Lihua, Prof. Tsang King Fung and Mr. Yu Jian. The notice was issued in Beijing on 14 April 2026 and signed by Chairman Dr. Lou Boliang.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Beijing Sets 28 April 2026 Board Meeting to Approve Q1 2026 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Beijing Sets 28 April 2026 Board Meeting to Approve Q1 2026 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-14 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. announced that its board of directors will convene on 28 April 2026 to review and approve the consolidated financial results for the three months ended 31 March 2026. The company plans to publish the first-quarter figures following the meeting.</p>\n<p>The board currently comprises nine members: Executive Directors Dr. Lou Boliang (Chairman), Mr. Lou Xiaoqiang and Ms. Zheng Bei; Employee Representative Director Mr. Li Shing Chung Gilbert; Non-executive Directors Mr. Li Jiaqing and Ms. Wan Xuan; and Independent Non-executive Directors Ms. Li Lihua, Prof. Tsang King Fung and Mr. Yu Jian. The notice was issued in Beijing on 14 April 2026 and signed by Chairman Dr. Lou Boliang.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1172374529","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172374529","pubTimestamp":1776161020,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. announced that its board of directors will convene on 28 April 2026 to review and approve the consolidated financial results for the three months ended 31 March 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成北京定于2026年4月28日召开董事会批准2026年第一季度业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. announced that its board of directors will convene on 28 April 2026 to review and approve the consolidated financial results for the three months ended 31 March 2026. The company plans to publish the first-quarter figures following the meeting.\nThe board currently comprises nine members: Executive Directors Dr. Lou Boliang (Chairman), Mr. Lou Xiaoqiang and Ms. Zheng Bei; Employee Representative Director Mr. Li Shing Chung Gilbert; Non-executive Directors Mr. Li Jiaqing and Ms. Wan Xuan; and Independent Non-executive Directors Ms. Li Lihua, Prof. Tsang King Fung and Mr. Yu Jian. The notice was issued in Beijing on 14 April 2026 and signed by Chairman Dr. Lou Boliang.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1172374529","isCrawlerRequest":true}